Eduardo Yepez Guevara, MD, FACP, is an Associate Professor in the Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas. He also serves as Fellowship Program Associate Director for the Infectious Diseases Fellowship and Associate Program Director for the Transplant and Oncology Infectious Diseases Fellowship. Dr.
Kamron Pourmand, MD is an Associate Professor in the Department of Medicine and Department of Medical Education at the Icahn School of Medicine at Mount Sinai. He serves as a transplant hepatologist in the Recanati/Miller Transplantation Institute at Mount Sinai. He provides specialized care to patients with acute and chronic liver disease, including cirrhosis, as well as caring for patients prior to and after liver transplantation.
Dr. Burchill is an associate professor of medicine in the division of Gastroenterology and Hepatology at the University of Colorado. His research aims to define the immune response in the liver during the progression of of chronic liver disease with a focus on dysfunction in both the liver lymphatic system and liver infiltrating T cells.
Assistant Professor of Medicine at Indiana University School of Medicine, interested in the mechanisms of liver fibrosis and chronic liver disease
Dr. Ding is a William Warner Abercrombie professor of the Department of Pharmacology, Toxicology, and Therapeutics at KUMC. The Ding laboratory has been working on the role of autophagy in alcohol and drug-induced liver injury since 2009. The Ding Lab is particularly interested in how autophagy selectively removes cellular damage and excess organelles, such as mitochondria and lipid droplets, in hepatocytes. Dr. Ding has extensive expertise in organelle stress and quality control in cell death and innate immunity in the pathogenesis of alcohol-associated liver disease and liver cancer.
Dr. Sudha Kodali obtained her medical degree from India and completed her residency training in Internal Medicine in Texas followed by fellowship in Gastroenterology and Hepatology at University of Alabama in Birmingham, a master's degree in Clinical and Translational Science from the UAB School of Public Health during her fellowship training period.
Dr. Bansal has been on faculty at Mount Sinai since 2001. In addition to maintaining an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV, Dr.
Dr. Lai is an Integrative Hepatologist who holds the Endowed Professorship of Liver Health & Transplantation at the University of California, San Francisco (UCSF).
Jessica Bartholomew, MSN, APRN, FNP-C, is a hepatology nurse practitioner and sub-investigator in Houston, Texas, focused on MASLD/MASH. She serves as Associate Lead for the AASLD MASLD Special Interest Group and is a member of the Global NASH/MASH Advanced Practice Providers (APP) Committee and GHAPP. She is passionate about advancing APP-led care in liver disease and has contributed to published recommendations guiding MASH management for APPs. Her interests include early detection, noninvasive testing, lifestyle modifications, and the evolving therapeutic pipeline.
Anthony Derencius is a Physician Assistant and Clinical Investigator at Pinnacle Clinical Research in San Antonio, Texas. His work experience includes clinical duties and care in general Gastroenterology, General Hepatology, and Transplant Hepatology in outpatient and inpatient roles. He was selected for a 2018 AASLD Foundation NP/PA Clinical Hepatology Fellowship Award and is an active member of both the Hepatology Associates Committee and Special Interest Group. He has served as the Hepatology Associates Committee Liaison to the Emerging Liver Advanced Practice Provider program.